Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	L-leucine binding	SESN3 UBR2	1.08e-04	7	46	2	GO:0070728
GeneOntologyMolecularFunction	structural constituent of skin epidermis	KRT75 KRT71 KRT74	1.32e-04	43	46	3	GO:0030280
GeneOntologyMolecularFunction	mRNA regulatory element binding translation repressor activity	CPEB2 CPEB4	6.91e-04	17	46	2	GO:0000900
GeneOntologyMolecularFunction	structural molecule activity	NPHP1 MRPL23 KRT75 KRT71 KRT74 KRT38 PPFIA2 MATN2	8.79e-04	891	46	8	GO:0005198
GeneOntologyBiologicalProcess	intermediate filament organization	KRT75 KRT71 KRT74 KRT38	1.96e-05	75	44	4	GO:0045109
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	KRT75 KRT71 KRT74 KRT38	5.85e-05	99	44	4	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament-based process	KRT75 KRT71 KRT74 KRT38	6.08e-05	100	44	4	GO:0045103
Domain	Intermediate_filament_CS	KRT75 KRT71 KRT74 KRT38	1.58e-05	63	45	4	IPR018039
Domain	Filament	KRT75 KRT71 KRT74 KRT38	2.54e-05	71	45	4	SM01391
Domain	Keratin_2_head	KRT75 KRT71 KRT74	2.55e-05	24	45	3	IPR032444
Domain	Keratin_2_head	KRT75 KRT71 KRT74	2.55e-05	24	45	3	PF16208
Domain	IF	KRT75 KRT71 KRT74 KRT38	2.68e-05	72	45	4	PS00226
Domain	Filament	KRT75 KRT71 KRT74 KRT38	2.83e-05	73	45	4	PF00038
Domain	Keratin_II	KRT75 KRT71 KRT74	3.27e-05	26	45	3	IPR003054
Domain	IF	KRT75 KRT71 KRT74 KRT38	3.32e-05	76	45	4	IPR001664
Domain	CEBP_ZZ	CPEB2 CPEB4	3.40e-05	4	45	2	IPR032296
Domain	CEBP_ZZ	CPEB2 CPEB4	3.40e-05	4	45	2	PF16366
Domain	RRM_7	CPEB2 CPEB4	3.40e-05	4	45	2	PF16367
Domain	Liprin	PPFIA2 PPFIA1	8.46e-05	6	45	2	IPR029515
Domain	Nucleotide-bd_a/b_plait	CPEB2 MRPL23 DGKQ CPEB4	3.40e-03	258	45	4	IPR012677
Domain	SAM_2	PPFIA2 PPFIA1	4.81e-03	43	45	2	PF07647
Domain	Ubiquitin-rel_dom	EZR DGKQ IQUB	9.85e-03	184	45	3	IPR029071
Domain	SAM_1	PPFIA2 PPFIA1	1.17e-02	68	45	2	PF00536
Domain	Prefoldin	KRT75 CEP135	1.30e-02	72	45	2	IPR009053
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	KRT75 KRT71 KRT74 KRT38	2.51e-04	129	34	4	M27649
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	PSMD2 PSME1 KALRN	7.10e-04	73	34	3	MM15285
Pathway	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	7.51e-04	17	34	2	MM14907
Pathway	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	7.51e-04	17	34	2	M93
Pathway	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	8.43e-04	18	34	2	M13015
Pathway	REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	8.43e-04	18	34	2	MM14702
Pathway	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	8.43e-04	18	34	2	MM14703
Pathway	REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	8.43e-04	18	34	2	M27043
Pathway	REACTOME_MITOTIC_G2_G2_M_PHASES	PSMD2 PSME1 LCMT1 CEP135	9.59e-04	184	34	4	MM15145
Pathway	REACTOME_HEDGEHOG_ON_STATE	PSMD2 EVC2 PSME1	9.62e-04	81	34	3	MM15225
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PPFIA2 PPFIA1	1.04e-03	20	34	2	M27290
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PPFIA2 PPFIA1	1.04e-03	20	34	2	MM14991
Pathway	REACTOME_HEDGEHOG_ON_STATE	PSMD2 EVC2 PSME1	1.14e-03	86	34	3	M27497
Pathway	REACTOME_UCH_PROTEINASES	PSMD2 PSME1 INO80	1.18e-03	87	34	3	MM15287
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	KRT75 KRT71 KRT74	1.18e-03	87	34	3	MM15351
Pathway	REACTOME_MITOTIC_G2_G2_M_PHASES	PSMD2 PSME1 LCMT1 CEP135	1.31e-03	200	34	4	M864
Pathway	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	1.38e-03	23	34	2	MM14852
Pathway	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	1.38e-03	23	34	2	M12627
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	PSMD2 PSME1 KALRN	1.43e-03	93	34	3	M27572
Pathway	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	1.51e-03	24	34	2	MM14834
Pathway	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 PPFIA1	1.51e-03	24	34	2	M630
Pathway	REACTOME_KERATINIZATION	KRT75 KRT71 KRT74 KRT38	1.76e-03	217	34	4	M27640
Pathway	REACTOME_UCH_PROTEINASES	PSMD2 PSME1 INO80	1.87e-03	102	34	3	M27576
Pubmed	New consensus nomenclature for mammalian keratins.	KRT75 KRT71 KRT74 KRT38	1.64e-06	63	47	4	16831889
Pubmed	CPEB2, a novel putative translational regulator in mouse haploid germ cells.	CPEB2 CPEB4	5.36e-06	3	47	2	12672660
Pubmed	Global Analysis of CPEBs Reveals Sequential and Non-Redundant Functions in Mitotic Cell Cycle.	CPEB2 CPEB4	5.36e-06	3	47	2	26398195
Pubmed	CPEB2-dependent translation of long 3'-UTR Ucp1 mRNA promotes thermogenesis in brown adipose tissue.	CPEB2 CPEB4	1.07e-05	4	47	2	30177570
Pubmed	Autosomal-dominant woolly hair resulting from disruption of keratin 74 (KRT74), a potential determinant of human hair texture.	KRT71 KRT74	1.07e-05	4	47	2	20346438
Pubmed	Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus.	CPEB2 CPEB4	1.07e-05	4	47	2	12871996
Pubmed	K6irs1, K6irs2, K6irs3, and K6irs4 represent the inner-root-sheath-specific type II epithelial keratins of the human hair follicle.	KRT71 KRT74	1.07e-05	4	47	2	12648212
Pubmed	A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons.	CPEB2 CPEB4	1.78e-05	5	47	2	20639532
Pubmed	The mouse and human Liprin-alpha family of scaffolding proteins: genomic organization, expression profiling and regulation by alternative splicing.	PPFIA2 PPFIA1	1.78e-05	5	47	2	19013515
Pubmed	Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins.	PPFIA2 PPFIA1	2.67e-05	6	47	2	21618221
Pubmed	A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.	PPFIA2 PPFIA1 STRIP2	3.37e-05	46	47	3	18782753
Pubmed	Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting.	PPFIA2 PPFIA1	3.74e-05	7	47	2	11931740
Pubmed	Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting.	PPFIA2 PPFIA1	6.40e-05	9	47	2	12629171
Pubmed	Interaction of the ERC family of RIM-binding proteins with the liprin-alpha family of multidomain proteins.	PPFIA2 PPFIA1	6.40e-05	9	47	2	12923177
Pubmed	RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.	KRT75 KRT71 KRT74	6.43e-05	57	47	3	31862882
Pubmed	Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK.	PPFIA2 PPFIA1	7.99e-05	10	47	2	18054859
Pubmed	Deficiency of CPEB2-Confined Choline Acetyltransferase Expression in the Dorsal Motor Nucleus of Vagus Causes Hyperactivated Parasympathetic Signaling-Associated Bronchoconstriction.	CPEB2 CPEB4	7.99e-05	10	47	2	27810937
Pubmed	NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses.	PSMD2 PSME1	9.75e-05	11	47	2	31114588
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CPEB2 SEPTIN8 PSMD2 PDE2A HK1 KALRN PPFIA2 PPFIA1 CPEB4	1.09e-04	1431	47	9	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EZR PSMD2 HK1 KRT75 KRT71 KRT74 PPFIA2 PPFIA1 LCMT1	1.16e-04	1442	47	9	35575683
Pubmed	Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.	PPFIA2 PPFIA1	1.17e-04	12	47	2	9624153
Pubmed	Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.	PSMD2 PSME1 HK1	1.24e-04	71	47	3	23503661
Pubmed	Hague (Hag). A new mouse hair mutation with an unstable semidominant allele.	KRT75 KRT71	2.12e-04	16	47	2	12399393
Pubmed	Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing.	CPEB2 CPEB4	2.70e-04	18	47	2	30111840
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	SEPTIN8 CCPG1 KALRN ZNF862	2.79e-04	233	47	4	37704626
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	EZR PSMD2 PSME1 HK1	3.08e-04	239	47	4	26641092
Pubmed	mSYD1A, a mammalian synapse-defective-1 protein, regulates synaptogenic signaling and vesicle docking.	PPFIA2 PPFIA1	3.34e-04	20	47	2	23791195
Pubmed	Planar cell polarity effector gene Intu regulates cell fate-specific differentiation of keratinocytes through the primary cilia.	KRT75 KRT71	3.69e-04	21	47	2	22935613
Pubmed	Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex.	PPFIA2 PPFIA1	7.59e-04	30	47	2	16186258
Pubmed	The synaptic vesicle cycle.	PPFIA2 PPFIA1	8.11e-04	31	47	2	15217342
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	EZR PHKA2 SEPTIN8 PSMD2 PSME1 HK1 KRT71	8.36e-04	1149	47	7	35446349
Pubmed	The AAA-ATPase ATAD1 and its partners promote degradation of desmin intermediate filaments in muscle.	PSMD2 PSME1	8.64e-04	32	47	2	36278411
Pubmed	Structure and functions of the 20S and 26S proteasomes.	PSMD2 PSME1	1.16e-03	37	47	2	8811196
Pubmed	An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.	PSMD2 PSME1	1.16e-03	37	47	2	9811770
Pubmed	Hypermutation of HIV-1 DNA in the absence of the Vif protein.	PSMD2 PSME1	1.16e-03	37	47	2	12750511
Pubmed	Death by deamination: a novel host restriction system for HIV-1.	PSMD2 PSME1	1.16e-03	37	47	2	12914693
Pubmed	Good to CU.	PSMD2 PSME1	1.16e-03	37	47	2	12840737
Pubmed	Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.	PSMD2 PSME1	1.16e-03	37	47	2	12719574
Pubmed	Evidence for a newly discovered cellular anti-HIV-1 phenotype.	PSMD2 PSME1	1.16e-03	37	47	2	9846577
Pubmed	DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses.	PSMD2 PSME1	1.16e-03	37	47	2	12830140
Pubmed	The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.	PSMD2 PSME1	1.22e-03	38	47	2	12808465
Pubmed	Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.	PSMD2 PSME1	1.22e-03	38	47	2	12808466
Pubmed	Virology. Weapons of mutational destruction.	PSMD2 PSME1	1.22e-03	38	47	2	12920286
Pubmed	HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.	PSMD2 PSME1	1.22e-03	38	47	2	14527406
Pubmed	Degradation of HIV-1 integrase by the N-end rule pathway.	PSMD2 PSME1	1.22e-03	38	47	2	10893419
Pubmed	The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.	PSMD2 PSME1	1.22e-03	38	47	2	14557625
Pubmed	DNA deamination mediates innate immunity to retroviral infection.	PSMD2 PSME1	1.22e-03	38	47	2	12809610
Pubmed	The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.	PSMD2 PSME1	1.22e-03	38	47	2	12970355
Pubmed	The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.	PSMD2 PSME1	1.22e-03	38	47	2	14614829
Pubmed	HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.	PSMD2 PSME1	1.28e-03	39	47	2	14528301
Pubmed	The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.	PSMD2 PSME1	1.35e-03	40	47	2	12419264
Pubmed	Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.	PSMD2 PSME1	1.35e-03	40	47	2	12167863
Pubmed	The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.	PSMD2 PSME1	1.35e-03	40	47	2	14528300
GeneFamily	Keratins, type II	KRT75 KRT71 KRT74	1.30e-05	27	31	3	609
GeneFamily	Proteasome	PSMD2 PSME1	2.46e-03	43	31	2	690
Coexpression	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP	EZR PDE2A FEM1C TK2 CPEB4	2.91e-05	200	47	5	M7856
Coexpression	GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP	SESN3 UBR2 PSME1 HK1 TOR3A	2.91e-05	200	47	5	M9051
Coexpression	GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP	SESN3 DENND5B SEPTIN8 HK1 CPEB4	2.91e-05	200	47	5	M7489
Coexpression	IKEDA_MIR30_TARGETS_UP	CPEB2 CCPG1 PPFIA1 CPEB4	5.61e-05	116	47	4	M2379
Coexpression	IKEDA_MIR30_TARGETS_UP	CPEB2 CCPG1 PPFIA1 CPEB4	5.80e-05	117	47	4	MM931
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CPEB2 CCDC80 PDE2A EVC2 KALRN	1.69e-06	190	47	5	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCPG1 TLR8 MATN2 MXD1	1.80e-05	148	47	4	ba277c898678dd36f8dc1d681301c71901b89055
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCPG1 TLR8 MATN2 MXD1	1.80e-05	148	47	4	b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CCDC80 EVC2 MATN2 STRIP2	2.56e-05	162	47	4	2d28306c6125b31f11ea6d911a167b93a74907c5
ToppCell	droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD3 CPEB2 DENND5B EVC2	2.75e-05	165	47	4	21a82a975f550080b6674750b06212205cd16742
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	KCNV1 KALRN PPFIA2 INKA2	2.95e-05	168	47	4	6db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCell	ASK454-Epithelial-Transformed_epithelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NPHP1 CCDC80 FEM1C STRIP2	3.24e-05	172	47	4	3986f0f098ef5e096c8d9ee3d335b8404083701f
ToppCell	CV-Mild-7\|Mild / Virus stimulation, Condition and Cluster	CPEB2 NPHP1 ZNF530 CPEB4	3.31e-05	173	47	4	c9bbca9313a0fdf146c8c995624b94b937e818d8
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN8 CCDC80 TSPY26P MATN2	3.62e-05	177	47	4	30f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCell	wk_20-22-Hematologic-Meg-ery-Platelet\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CPEB2 KALRN INKA2 CPEB4	3.95e-05	181	47	4	724efbc200e8388829bc7d81830c2689a95fa838
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SESN3 CCDC80 DPP10 MATN2	4.39e-05	186	47	4	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABHD3 DPP10 DMRT2 CPEB4	4.39e-05	186	47	4	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 EZR CCDC80 IQUB	4.67e-05	189	47	4	b4b93bd10b7e3cc16e54ff73beac230f519c010a
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 EZR CCDC80 IQUB	4.87e-05	191	47	4	683e5c7e6173644f01e67c98ab7b75d7cb9cce99
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	EZR PSMD2 PPFIA1 STRIP2	4.97e-05	192	47	4	4e689bca7a242f8482e25f273656e2caba8821c0
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNV1 DPP10 KALRN PPFIA2	5.07e-05	193	47	4	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNV1 DPP10 KALRN PPFIA2	5.07e-05	193	47	4	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	(2)_B_cell-(21)_B_cell_IgG_Plasma\|(2)_B_cell / shred on Cell_type and subtype	PSMD2 CCPG1 TOR3A CPEB4	5.82e-05	200	47	4	2831060d52b210f8927527810611735a99b61999
ToppCell	(21)_B_cell_IgG_Plasma\|World / shred on Cell_type and subtype	PSMD2 CCPG1 TOR3A CPEB4	6.16e-05	203	47	4	15055e1b1017afbdb2a567972cbb976deb7d4e6a
Disease	Woolly hair, congenital	KRT71 KRT74	2.48e-05	5	47	2	C0345427
Disease	Hypotrichosis	KRT71 KRT74	3.71e-05	6	47	2	C0020678
Disease	Wooly hair	KRT71 KRT74	5.19e-05	7	47	2	C0343073
Disease	breast milk measurement	EVC2 INO80 KALRN	6.51e-04	106	47	3	EFO_0009092
Disease	Mammary Carcinoma, Animal	EZR PSME1 KRT71	1.52e-03	142	47	3	C1257925
Disease	Animal Mammary Neoplasms	EZR PSME1 KRT71	1.52e-03	142	47	3	C0024667
Disease	Mammary Neoplasms, Experimental	EZR PSME1 KRT71	1.95e-03	155	47	3	C0024668
Disease	Carcinomatosis	EZR PSME1 KRT71	2.25e-03	163	47	3	C0205699
Disease	Carcinoma, Spindle-Cell	EZR PSME1 KRT71	2.25e-03	163	47	3	C0205697
Disease	Undifferentiated carcinoma	EZR PSME1 KRT71	2.25e-03	163	47	3	C0205698
Disease	Anaplastic carcinoma	EZR PSME1 KRT71	2.25e-03	163	47	3	C0205696
Disease	Carcinoma	EZR PSME1 KRT71	2.28e-03	164	47	3	C0007097
Disease	visceral:gluteofemoral adipose tissue ratio measurement	DPP10 CPEB4	2.35e-03	45	47	2	EFO_0803319
Disease	visceral:abdominal adipose tissue ratio measurement	DMRT2 CPEB4	3.13e-03	52	47	2	EFO_0803318

Protein segments in the cluster

Peptide	Gene	Start	Entry
EAERLYMLLKDMAVR	DGKQ	551	P52824
MDLRMLSRELSLYLE	ABHD3	6	Q8WU67
AERALREMRDLLMNL	GLE1	311	Q53GS7
MDRNQYALLLIMDEE	DPP10	556	Q8N608
MVIVYDLIDSMQLRR	CCDC80	886	Q76M96
LIYSQMTRMIDLLEE	INO80	1121	Q9ULG1
DEMRMQALLIRERIL	FEM1C	316	Q96JP0
RMNIQMLLEAADYLE	MXD1	6	Q05195
EMTQRMEALENRLRY	MATN2	941	O00339
REMDCYLRRLKQELM	INKA2	6	Q9NTI7
MNRNILEEMLQYLLI	LRRC37A5P	1	Q49AS3
RVLGEMRAQYEAMLE	KRT38	271	O76015
VNLRDVYARSIMEML	KCNV1	466	Q6PIU1
RKDYQRMLDLMRDII	PDE2A	751	O00408
ILELMDDGRLLDYLM	KALRN	2756	O60229
GYLDEDQMEMLLERA	EVC2	631	Q86UK5
FEQLMVSMLEERDRL	PPFIA1	36	Q13136
LYAMRLSDETLIDIM	HK1	26	P19367
MERMLELFEQNRDRI	TK2	241	O00142
DELQRMLERFEKYME	CEP135	506	Q66GS9
IRMDEFRQIIQRYML	CCPG1	651	Q9ULG6
LRAVELAMIMDRLYG	CPEB2	451	Q7Z5Q1
ENIMLEREYKEREML	DMRT2	246	Q9Y5R5
ITRMYEESALLRDRM	DENND5B	1231	Q6ZUT9
EILELIDREVDLMMR	IQUB	536	Q8NA54
LRAVELAMIMDRLYG	CPEB4	591	Q17RY0
MREKEELMLRLQDYE	EZR	341	P15311
EAEYRDIRLMVMEIR	PSME1	206	Q06323
YLIVLMRNRMETVED	NPHP1	271	O15259
YLALDNEMIVEMLRI	PHKA2	531	P46019
NEMIVEMLRIELAYL	PHKA2	536	P46019
FEQLMVNMLDERDRL	PPFIA2	31	O75334
MYLMVENIRLERETD	STRIP2	206	Q9ULQ0
FLDEMELLEQLMRHY	LCMT1	301	Q9UIC8
LRLALMLNDMELVED	PSMD2	266	Q13200
YLALQRLMDENMDVI	TLR8	961	Q9NR97
LMEARMQAELLYALR	SESN3	471	P58005
MEMTRVDLRNYLEGI	MRPL23	46	Q16540
LREMLIRVNMEDLRE	SEPTIN8	276	Q92599
ELYRDVMRMNYELLA	ZNF862	356	O60290
LDMAQRNLYRDVMLE	ZNF66	21	Q6ZN08
LDEMQRLLYRDVMLE	ZNF530	31	Q6P9A1
RLLYRDVMLENFAVM	ZNF530	36	Q6P9A1
VARMLVENLYRDGLM	TOR3A	176	Q9H497
DMLCYLMNLEVRELR	TSPY26P	216	Q9H489
EEMLYLIIMLVGERF	UBR2	751	Q8IWV8
DMARLLREYQELMNI	KRT75	426	O95678
EELARMLREYQELMS	KRT71	406	Q3SY84
EELARMLREYQELMS	KRT74	416	Q7RTS7